Review
Open access
Jul 2026
Unravelling recent advances in 1,2,4-triazole-based anticancer agents: synthetic strategies, molecular targets, molecular docking studies, and structure–activity relationships
Recent advances in 1,2,4-triazole chemistry and its biological role in the development of anticancer targets through the inhibition of EGFR, VEGFR-2 and different carbonic anhydrase enzymes are presented.
Glanish Jude Martis, Eshitha Jane D. Souza, Praveen S. Mugali et al.
· RSC Advances · 0 citations